In this guest commentary, Upendra Marathi and Joseph Bailes propose two key incentives to boost drug repositioning for COVID-19: restoring BARDA funding and extending market exclusivity for repurposed drugs, offering critical support for expanding the pipeline of treatments for COVID-19.